The HIV research group conducts a wide range of clinical trials offering experimental treatments with antiretrovirals and immune therapy for adults at all stages of HIV disease.
Current studies are sponsored by the AIDS Clinical Trials Group (ACTG) and the AIDS Malignancy Consortium. ACTG trials are funded by the National Institute of Allergy and Infectious Diseases (NAIDS).
Study medications and related tests are in most cases free of charge. Additional HIV/AIDS studies sponsored by drug companies are sometimes available. The research group is located at the Infectious Diseases Clinic.
For more information about studies contact Jim Scott at 303-602-8741 or james.scott@dhha.org.
